Lung Cancers Terminated Phase 3 Trials for Talabostat (DB06182)

Also known as: Lungcancer / Cancer, Lung / Lung Cancer / Lung cancer NOS / Primary malignant neoplasm of lung (disorder) / Lung neoplasm malignant / Cancer of lung / Ca lung / Malignant tumor of lung (disorder)

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00290017Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyTreatment